Share ownership Shanghai Shyndec Pharmaceutical Co., Ltd.
Equities
600420
CNE000001JG2
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.86 CNY | -0.18% |
|
+1.12% | -9.05% |
07-01 | Shyndec Pharmaceutical Unit Gets Registration Certificate for Hypertension Drug in China | MT |
06-05 | Shyndec Pharmaceutical's Two Drugs Pass Regulatory Evaluation | MT |
Share class: Shanghai Shyndec Pharmaceutical Co., Ltd.
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,341,172,692 | 559,857,631 ( 41.74 %) | 0 | 41.74 % |
Major shareholders: Shanghai Shyndec Pharmaceutical Co., Ltd.
Name | Equities | % | Valuation |
---|---|---|---|
China Merchants Fund Management Co., Ltd.
0.7535
%
| 10,105,305 | 0.7535 % | 15 M ¥ |
China Southern Asset Management Co., Ltd.
0.4277
%
| 5,735,700 | 0.4277 % | 9 M ¥ |
China Asset Management Co., Ltd.
0.2891
%
| 3,877,310 | 0.2891 % | 6 M ¥ |
Guolian Fund Management Co. Ltd.
0.2877
%
| 3,857,900 | 0.2877 % | 6 M ¥ |
Fullgoal Fund Management Co., Ltd.
0.2408
%
| 3,229,100 | 0.2408 % | 5 M ¥ |
Huisheng Fund Management Co., Ltd.
0.1459
%
| 1,957,100 | 0.1459 % | 3 M ¥ |
Zhong Ou Asset Management Co., Ltd
0.1184
%
| 1,588,010 | 0.1184 % | 2 M ¥ |
Tian Hong Asset Management Co., Ltd.
0.1132
%
| 1,517,717 | 0.1132 % | 2 M ¥ |
Essence Fund Co., Ltd.
0.0916
%
| 1,228,900 | 0.0916 % | 2 M ¥ |
Wanjia Asset Management Co., Ltd.
0.088
%
| 1,180,900 | 0.088 % | 2 M ¥ |
░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░ ░░░ | ░░░░% | ░░ |
Breakdown by shareholder type
Institutional | 3.2% |
Unknown | 96.8% |
Based on 1000 largest holdings
Geographical origin of shareholders
China | 3.07% |
United Kingdom | 0.07% |
Australia | 0.03% |
Hong Kong | 0.01% |
Ireland | 0.01% |
Based on 1000 largest holdings
Employees
11,472
Sector
Pharmaceuticals
Calendar
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition